Novel agents for cancer therapy

In this topical collection (17 articles)

1. Review

   STAT inhibitors for cancer therapy

   Muhammad Furqan, Akintunde Akinleye, Nikhil Mukhi… Article:90

   Download PDF (483KB) View Article

2. Review

   Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics

   Akintunde Akinleye, Parthu Avvaru, Muhammad Furqan… Article:88

   Download PDF (999KB) View Article

3. Research highlight

   SWI/SNF proteins as targets in cancer therapy

   Santiago Schiaffino-Ortega, Carlos Balinas… Article:81

   Download PDF (310KB) View Article

4. Review

   Strategies for modern biomarker and drug development in oncology

   Alan D Smith, Desam Roda, Timothy A Yap Article:70

   Download PDF (957KB) View Article

5. Research

   Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G₂ checkpoint and suppression of homologous recombination repair

   Qin Qin, Hongyan Cheng, Jing Lu, Liangliang Zhan… Article:62

   Download PDF (2818KB) View Article

6. Review

   Ibrutinib and novel BTK inhibitors in clinical development

   Akintunde Akinleye, Yamei Chen, Nikhil Mukhi… Article:59

   Download PDF (622KB) View Article

7. Review

   New antibody approaches to lymphoma therapy

   Tejas Suresh, Lisa X Lee, Jitesh Joshi, Stefan K Barta Article:58

   Download PDF (978KB) View Article

8. Review

   Signal transduction inhibitors in treatment of myelodysplastic syndromes

   Lohith Bachegowda, Oleg Gligich, Ionnis Mantzaris… Article:50

   Download PDF (1284KB) View Article

9. Review

   Novel agents and biomarkers for acute lymphoid leukemia

   Yanmin Zhao, He Huang, Guoqing Wei Article:40

   Download PDF (380KB) View Article

10. Review

    Targeted therapy for HER2 positive breast cancer

    Jason A Incorvati, Shilpan Shah, Ying Mu, Janice Lu Article:38

    Download PDF (341KB) View Article

11. Research

    A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies

    Caroline S Breton, Aimable Nahimana, Dominique Aubry… Article:33

    Download PDF (1362KB) View Article

12. Review

    B-Raf and the inhibitors: from bench to bedside

    Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong… Article:30

    Download PDF (664KB) View Article

13. Review

    MEK and the inhibitors: from bench to bedside

    Akintunde Akinleye, Muhammad Furqan, Nikhil Mukhi… Article:27

    Download PDF (813KB) View Article

14. Review

    Targeting p53 by small molecules in hematological malignancies

    Manujendra N Saha, Lugui Qiu, Hong Chang Article:23

    Download PDF (478KB) View Article

15. Review

    Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies

    Raoul Tibes, Ruben A Mesa Article:18

    Download PDF (1002KB) View Article

16. Research

    Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

    Bertrand Coiffier, Barbara Pro, H Miles Prince… Article:11

    Download PDF (743KB) View Article

17. Review

    Homoharringtonine and omacetaxine for myeloid hematological malignancies

    Shuqing Lü, Jianmin Wang Article:2

    Download PDF (598KB) View Article